| Jonathan Benjamin Macknin, MD | |
|
13207 Ravenna Rd, Chardon, OH 44024-7032 | |
| (440) 285-5004 | |
| (440) 285-6985 |
| Full Name | Jonathan Benjamin Macknin |
|---|---|
| Gender | Male |
| Speciality | Hand Surgery |
| Experience | 16 Years |
| Location | 13207 Ravenna Rd, Chardon, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740442730 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 35.135189 (Ohio) | Secondary |
| 207XS0106X | Orthopaedic Surgery - Hand Surgery | 35.135189 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Uh Regional Hospitals | Richmond heights, OH | Hospital |
| University Hospitals Of Cleveland | Cleveland, OH | Hospital |
| Lake Health | Concord, OH | Hospital |
| University Hospitals Ahuja Medical Center | Beachwood, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Primary Care Practices Inc | 3072417534 | 940 |
News Archive
Three months and more than 37,000 pounds later, The Biggest Loser Summer Challenge has a winner: Blue Cross and Blue Shield of Minnesota and its employees, who lost more than 3,780 pounds or 2.80 percent of their total weight in pounds per employee since Memorial Day.
A new report by the Centre for Drug Misuse Research at the University of Glasgow reveals that the number of people misusing heroin in Scotland has dropped. The research shows a near eight per cent drop in the number of problem drug users since 2000.
The Belgian biotechnology company, Cardio3 BioSciences (C3BS), a leader in the discovery and development of regenerative and protective therapies for the treatment of cardiovascular diseases, today announces that the final results of its Phase II clinical trial of C3BS-CQR-1 is will be presented at the late breaking clinical trial session at the European Society of Cardiology 2012 Heart Failure Congress in Belgrade, Serbia taking place on May 19-22.
In recent years, measures have been introduced to reduce the rate of "antipsychotic polypharmacy"—taking more than one antipsychotic drug—among patients with schizophrenia and other serious mental illnesses.
ARIAD Pharmaceuticals, Inc. today announced that it has restructured its July 2007 collaboration with Merck, Sharpe & Dohme Corp. for the development, manufacture, and commercialization of ridaforolimus - ARIAD's investigational mTOR inhibitor.
› Verified 7 days ago
| Entity Name | University Primary Care Practices Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003935339 PECOS PAC ID: 3072417534 Enrollment ID: O20031125000767 |
News Archive
Three months and more than 37,000 pounds later, The Biggest Loser Summer Challenge has a winner: Blue Cross and Blue Shield of Minnesota and its employees, who lost more than 3,780 pounds or 2.80 percent of their total weight in pounds per employee since Memorial Day.
A new report by the Centre for Drug Misuse Research at the University of Glasgow reveals that the number of people misusing heroin in Scotland has dropped. The research shows a near eight per cent drop in the number of problem drug users since 2000.
The Belgian biotechnology company, Cardio3 BioSciences (C3BS), a leader in the discovery and development of regenerative and protective therapies for the treatment of cardiovascular diseases, today announces that the final results of its Phase II clinical trial of C3BS-CQR-1 is will be presented at the late breaking clinical trial session at the European Society of Cardiology 2012 Heart Failure Congress in Belgrade, Serbia taking place on May 19-22.
In recent years, measures have been introduced to reduce the rate of "antipsychotic polypharmacy"—taking more than one antipsychotic drug—among patients with schizophrenia and other serious mental illnesses.
ARIAD Pharmaceuticals, Inc. today announced that it has restructured its July 2007 collaboration with Merck, Sharpe & Dohme Corp. for the development, manufacture, and commercialization of ridaforolimus - ARIAD's investigational mTOR inhibitor.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jonathan Benjamin Macknin, MD 13207 Ravenna Rd., Attn: Orthopedic Surgery, Chardon, OH 44024-7032 Ph: (440) 285-5004 | Jonathan Benjamin Macknin, MD 13207 Ravenna Rd, Chardon, OH 44024-7032 Ph: (440) 285-5004 |
News Archive
Three months and more than 37,000 pounds later, The Biggest Loser Summer Challenge has a winner: Blue Cross and Blue Shield of Minnesota and its employees, who lost more than 3,780 pounds or 2.80 percent of their total weight in pounds per employee since Memorial Day.
A new report by the Centre for Drug Misuse Research at the University of Glasgow reveals that the number of people misusing heroin in Scotland has dropped. The research shows a near eight per cent drop in the number of problem drug users since 2000.
The Belgian biotechnology company, Cardio3 BioSciences (C3BS), a leader in the discovery and development of regenerative and protective therapies for the treatment of cardiovascular diseases, today announces that the final results of its Phase II clinical trial of C3BS-CQR-1 is will be presented at the late breaking clinical trial session at the European Society of Cardiology 2012 Heart Failure Congress in Belgrade, Serbia taking place on May 19-22.
In recent years, measures have been introduced to reduce the rate of "antipsychotic polypharmacy"—taking more than one antipsychotic drug—among patients with schizophrenia and other serious mental illnesses.
ARIAD Pharmaceuticals, Inc. today announced that it has restructured its July 2007 collaboration with Merck, Sharpe & Dohme Corp. for the development, manufacture, and commercialization of ridaforolimus - ARIAD's investigational mTOR inhibitor.
› Verified 7 days ago
Kraig K Solak, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 150 7th Ave Ste 200, Chardon, OH 44024 Phone: 440-285-4999 Fax: 440-285-5870 | |
Michael Lynn Fisher, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 150 7th Ave Ste 200, Chardon, OH 44024 Phone: 440-285-4999 Fax: 440-285-5870 | |
Albert S Dunn, Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 150 7th Ave Ste 200, Chardon, OH 44024 Phone: 440-285-4999 Fax: 440-285-5870 | |
George J Kellis, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 150 7th Ave Ste 200, Chardon, OH 44024 Phone: 440-285-4999 Fax: 440-285-5870 | |
Scott M Zimmer, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 13170 Ravenna Road, Suite 200, Chardon, OH 44024 Phone: 844-542-6363 Fax: 440-279-1582 | |
Laszlo S Harmat, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 150 7th Ave Ste 200, Chardon, OH 44024 Phone: 440-285-4999 Fax: 440-285-5870 |